Revolutionizing Complex Care Management

Our Mission: Empowering Patients and Providers with Innovative Solutions

Reimagining Healthcare for Complex Conditions

Our vision is a world without geographical or systemic barriers to the best medical expertise. With Ensemble, we're creating a future where patients with complex conditions receive truly coordinated, personalized care from a global network of top specialists.

Our Guiding Principles

Patient-Centric Care

Everything we do is focused on improving patient outcomes and experiences. We prioritize the needs of the patients and families above all.

Collaboration as a Priority

We are committed to ensuring patients with complex medical conditions not only get access to the specialist they need, but to ensuring that those specialists work together in close collaboration to provide holisti care.

Continuous Innovation

There is no excuse for the health of those we love to be in the hands of outdated systems and processes. We're committed to pushing healthcare forward.

Trust and Security

We build a culture of security and trust into everything we do.

Whether you're a patient seeking coordinated care for a complex condition or a healthcare provider looking to expand your impact, there's a place for you in the Blue Clay Health community.

Be Part of the Healthcare Revolution

Join our Waitlist

Our Team

Meet the team behind Blue Clay Health

Chris is a serial entrepreneur and former Navy warship captain. He is a graduate of the United States Naval Academy and Harvard Business School.

Chris Riley

Founder & CEO

Describe the team member here. Write a brief description of their role and responsibilities, or a short bio with a background summary.

TBD

Senior Medical Advisor

Describe the team member here. Write a brief description of their role and responsibilities, or a short bio with a background summary.

Andrew Livingston

User Experience & Innovation

Born From Personal Experience

Blue Clay Health was founded by Chris Riley after his son suffered a life-altering stroke. Navigating the complexities of the healthcare system revealed critical gaps in care coordination for complex conditions. This personal journey inspired the creation of Ensemble – a platform designed to revolutionize how patients with complex medical needs access and receive coordinated, expert care.

Guided by Industry Leaders

Our Board of Advisors

Dana DiFerdinando

Dana DiFerdinando, a global healthcare and life sciences technology executive, joins Blue Clay Health's Board of Advisors. She brings extensive experience from roles such as Chief Data Officer at GE Healthcare and leading Advanced Analytics at ResMed. Recognized by WomenTech Network and CDO Magazine, Dana holds an MS in Operations Research from Stanford and a BS in Computer Science from Rutgers, aligning her expertise with Blue Clay Health's mission to transform care for patients with complex medical conditions.

Dr. Garth Graham

Dr. Garth Graham, a cardiologist and public health expert, joins Blue Clay Health's Board of Advisors. As Director and Global Head of Healthcare and Public Health at Google Health/YouTube, he brings extensive experience from roles in two US administrations and at the University of Florida, Aetna Foundation, and CVS Health. An elected member of the National Academy of Medicine, Dr. Graham holds an MD and MPH from Yale and completed his residency at Massachusetts General and fellowship at Johns Hopkins. His expertise aligns with Blue Clay Health's mission to transform care for patients with complex medical conditions.

Guadalupe Hayes-Mota

Guadalupe Hayes-Mota, an entrepreneur, MIT professor, and business leader in healthcare, joins Blue Clay Health's Board of Advisors. Driven by his personal battle with a rare disease, his extensive experience in healthcare innovation and global supply chain management aligns with Blue Clay Health's mission. As founder and CEO of Healr Solutions, Guadalupe led the company to a 200% revenue increase, expanding to 43 countries before its 2024 acquisition. His roles at Biogen, Amgen, and GSK significantly impacted global healthcare. Recognized by PharmaVoice and Entrepreneur Magazine, Guadalupe holds multiple degrees from Harvard, Georgetown, and MIT, making him a valuable asset to Blue Clay Health.

Sharon Mills-Higgins

Sharon Higgins, a seasoned executive leader dedicated to improving healthcare for all populations, joins Blue Clay Health's Board of Advisors. Her innovative thinking and data-driven decision-making align with Blue Clay Health's mission. Sharon serves as Chair of the National Board of Trustees of the March of Dimes, leading a successful $50 million capital campaign as interim CEO. Previously, she held various positions at Xerox, rising to Marketing Director, managing a 500-person team and a $300 million budget. Sharon also serves on the boards of Nemours Children's Health System and Partners in Outreach, bringing valuable leadership to Blue Clay Health.

Mei Jiang

Mei Jiang, a results-driven digital leader and serial entrepreneur, joins Blue Clay Health's Board of Advisors. With over 20 years of experience in both large corporations and startups, Mei has a consistent track record of driving billion-dollar growth and creating new markets. Mei's passion lies in transforming technology into profit and scaling businesses. She has led three exits totaling over $1.5B, including an IoT startup acquired by Lockheed for $500M. At Iron Mountain and Medtronic, her initiatives led to significant growth. Mei's expertise in digital transformation aligns perfectly with Blue Clay Health's mission to revolutionize patient care.

Dr. Eneida Roldan

Dr. Eneida O. Roldan, a distinguished healthcare executive and educator with over 30 years of experience, joins Blue Clay Health's Board of Advisors. Her extensive background in healthcare management, public health, and medical education aligns perfectly with Blue Clay Health's mission. Dr. Roldan has served as President and CEO of both public and private hospital systems, bringing a wealth of leadership experience. She is a renowned speaker, author, and board member of multiple medical and civic organizations. Dr. Roldan holds an MD from the University of Miami, an MPH from the University of South Florida, and an MBA from the University of Tennessee, making her an invaluable addition to Blue Clay Health.

Dr. Sandra Stratford

Dr. Sandra Stratford, a distinguished physician and leader in occupational and digital health, joins Blue Clay Health's Board of Advisors. She brings extensive expertise in enhancing employee health, safety, and productivity. As Chief Medical Officer at Raytheon, Dr. Stratford launched health programs for 70,000 employees worldwide. She also serves on the board of Aifred Health and as a Trustee for Dana-Farber Cancer Institute. Recognized by the National Medical Fellowship and Boston Business Journal, Dr. Stratford holds degrees from Yale, Hahnemann University, and Mount Sinai, and a Certificate in Business Excellence from Columbia. Her dedication to healthcare innovation makes her invaluable to Blue Clay Health.

Jenni Vargas

Jenni Vargas joins Blue Clay Health's Board of Advisors, bringing extensive experience in healthcare strategy and transformation. Most recently, she served as Chief Strategy Officer at One Medical, overseeing growth in Virtual Care, Pediatrics, and Behavioral Health services. Jenni has driven growth through strategic acumen and industry knowledge, transforming healthcare to be higher value and more consumer-friendly. Previously, she was Chief Strategy Officer at Stanford Health Care, launching several key initiatives. With 20 years in P&L roles at health insurance companies and service on various nonprofit boards, Jenni's expertise aligns perfectly with Blue Clay Health's mission to revolutionize care for patients with complex medical conditions.